Interleukin-1β-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methyl xanthine

European Journal of Endocrinology

Volumn 134, Issue 2, 1996, Pages 251-259

  Andersen, Henrik U ^a   Mauricio, Dídac ^a   Karlsen, Allan E ^a   Mandrup Poulsen, Thomas ^a   Nielsen, Jens H ^b   Nerup, Jørn ^a  

^a STENO DIABETES CENTER   (Denmark)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; BUCLADESINE; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; ISOBUTYLMETHYLXANTHINE; LEUCINE; NITRIC OXIDE SYNTHASE; TOLBUTAMIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; NEWBORN; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT;

EID: 0029670692     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340251     Document Type: Article

References (44)

1. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH. Affinity purified human Interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 1986;29:63-7
2. Spinas GA, Mandrup-Poulsen T, Mølvig J, Bæk L, Bendtzen K, Dinarello CA. et al. Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endorcrinol (Copenh) 1986;113:551-8
3. Sandler S, Andersson A, Hellerström C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987;121:1424-31
4. Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen JH, Dinarello CA. Ultrastructural studies of time course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand Sect C 1987;95:55-63
5. Sandler S, Bendtzen K, Borg LAH, Eizirik DL, Strandell E, Welsh N. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1β indicate a perturbation in the mitochondrial function. Endocrinology 1989;124:1492-501
6. Spinas GA, Palmer JP, Mandrup-Poulsen T, Andersen H, Nielsen JH, Nerup J. The bimodal effect of interleukin 1 on rat pancreatic beta-cells-stimulation followed by inhibition-depends upon dose, duration of exposure, and ambient glucose concentration. Acta Endocrinol (Copenh) 1988;119:307-11
7. Nerup J, Mandrup-Poulsen T, Malvig J, Helqvist S, Wogensen L, Egeberg J. Mechanisms of pancreatic β-cell destruction in type I diabetes. Diabetes Care 1988;11 Suppl 1:16-23
8. Mandrup-Poulsen T, Spinas GA, Prowse SJ, Hansen BS, Jørgensen DW, Bendtzen K, et al. Islet cytotoxicity of interleukin 1: influence of culture conditions and islet donor characteristics. Diabetes 1987;36:641-7
9. Sandler S, Bendtzen K, Eizirik DL, Strandel E, Welsh N, Welsh M. Metabolism and β-cell function of rat pancreatic islets exposed to human interleukin-15 in the presence of a high glucose concentration. Immunol Lett 1990;26:245-52
10. Pipeleers D, Van De Winkel M. Pancreatic B cells possess defense mechanisms against cell-specific toxicity. Proc Natl Acad Sci USA 1986;83:5267-71
11. Corbett JA, McDaniel ML. Does nitric oxide mediate autoimmune destruction of β-cell? Possible therapeutic interventions in IDDM. Diabetes 1992;41:897-903
12. Marietta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 1993;268:12231-4
13. Karlsen AE, Andersen HU, Vissing H, Cuartero BG, Madsen OD, Petersen JS, et al. Cloning and expression of a cytokine inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes 1995;44:753-8
14. Schmidt HHHW, Warner TD, Ishii K, Sheng H, Murad F. Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science 1992;255:721-3
15. Laychock SG, Modica ME, Cavanaugh CT. L-Arginine stimulates cyclic guanosine 3′,5′-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase. Endocrinology 1991;129:3043-52
16. Corbett JA, McDaniel ML. Intratslet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J Exp Med 1995;181:559-68
17. Corbett JA, Wang JL, Sweetland MA, Lancaster Jr JR, McDaniel ML. IL-1β induces the formation of nitric oxide by β-cells purified from islets of Langerhans: evidence for the β-cell as source and site of action of nitric oxide. J Clin Invest 1993;90:2384-91
18. Eizirik DL, Cagliero E, Björklund A, Welsh N. Interleukin-1β induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages. FEBS Lett 1992;308:249-52
19. Welsh N, Eizirik DL, Bendtzen K, Sandler S. Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991;129:3167-73
20. Suschek C, Fehsei K, Kröncke K-D, Sommer A, Kolb-Bachofen V. Primary cultures of rat islet capillary endothelial cells. Constitutive and cytokine-inducible macrophagelike nitric oxide synthases are expressed and activities regulated by glucose concentration. Am J Pathol 1994;145:685-95
21. Koide M, Kawahara Y, Nakayama I, Tsuda T, Yokoyama M. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. J Biol Chem 1993;268:24959-66
22. Imai T, Hirata Y, Kanno K, Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J Clin Invest 1994;93:543-9
23. Messmer U, Brune B. Modulation of inducible nitric oxide synthase in RINm5F cells. Cell Signal 1994;6:17-24
24. Mølvig J, Hansen BS, Worsaae H, Hejnæs KR, Helle M, Dalbøge H, et al. Comparison of biological and immunological activities of human monocyte-derived interleukin 1β and human recombinant interleukin 1β. Scand J Immunol 1990;31:225-35
25. Brunstedt J, Nielsen JH, Lernmark Å, and The Hagedorn Study Group. Isolation of islets from mice and rats. In: Larner J, Pohl SL, editors. Methods in diabetes research, Vol. 1, Laboratory methods. Part C. New York: Wiley, 1984:254-88
26. 15N] nitrate in biological fluids. Anal Biochem 1982;126:131-8
27. Heding LG. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972;8:260-6
28. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, et al. Cloning and primary structure of a human islet isoform of glutamic acid carboxylase from chromosome 10. Proc Natl Acad Sci USA 1991;88:8337-41
29. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992;41:552-6
30. Sharma K, Danoff TM, DePiero A, Ziyadeh FN. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C. Biochem Biophys Res Commun 1995;207:80-8
31. Eizirik DL, Strandell E, Sandler S. Culture of mouse pancreatic islets in different glucose concentrations modifies B cell sensitivity to streptozotocin. Diabetologia 1988;31:168-74
32. Granger DL, Taintor RR, Cook JL, Hibbs Jr JB. Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J Clin Invest 1980;65:357-70
33. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, and pharmacology. Pharmacol Rev 1991;43:109-42
34. Harbrecht BG, Johnson B, Pitt B, Billiar TR. Differential regulation of inducible nitric oxide synthase (iNOS) by cyclic AMP in vascular smooth muscle cells and hepatocytes [Abstract]. Endothelium Suppl 1995;3:S25
35. Zähner D, Malaisse WJ. Effects of advanced glycation products and aminoguanidine upon insulin release. Diabet Nutr Metab 1992;5:43-6
36. Tasaka Y, Nakaya F, Matsumoto H, Omori Y. Effects of aminoguanidine on insulin release from pancreatic islets. Endocr J 1994;41:309-13
37. Holstad M, Jansson L, Sandler S. Effects of aminoguanidine on rat pancreatic islets in culture, and on the pancreatic islet blood flow of anesthetized rats [Abstract]. Diabetologia 1995;38 Suppl 1:A95
38. Corbett JA, Wang JL, Zhao W, Hickey WF, McDaniel ML. Nitric oxide mediates IL-1-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity 1993;15:145-53
39. Cetkovic-Cvrtje M, Eizirik DL. TNF-α and INF-γ potentiate the deleterious affects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 1994;6:399-406
40. Southern C, Schulster D, Green IC. Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 1990;276:42-4
41. Andersen HU, Jørgensen KH, Egeberg J, Mandrup-Poulsen T, Nerup J. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 1994;43:770-7
42. Sumoski W, Baquenzo H, Rabinovitch A. Oxygen free radical scavengers protect rat islets cells from damage by cytokines. Diabetologia 1989;32:792-6
43. Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller DA, et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 1994;93:1968-74
44. Stjernesjö J, Bendtzen K, Sandler S. Effects of prolonged exposure in vitro to interferon-γ and tumor necrosis factor-α on nitric oxide and insulin production of rat pancreatic islets. Autoimmunity 1995;20:185-90